http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-101068267-B1
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2236-333 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2236-331 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K36-482 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P17-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K36-482 |
| filingDate | 2009-07-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2011-09-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2011-09-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | KR-101068267-B1 |
| titleOfInvention | Pharmaceutical composition for the treatment of vitiligo containing an extract of Seok-myung as an active ingredient |
| abstract | The present invention is the name of Cassia The present invention relates to a pharmaceutical composition for treating vitiligo, which contains an occidentalis extract as an active ingredient. Specifically, the crystallized extract of the present invention relates to the induction of tyrosinase activation and melanin production in an inactive melanoblast, And it relates to a pharmaceutical composition for treating vitiligo inducing pigment re-deposition of the bleaching site by promoting cell migration to epidermal tissue. The composition of the present invention is not only cytotoxic but also promotes the differentiation and migration of melanoblast, so it can be usefully used for the treatment of vitiligo.n n n n Stone Name, Melanin, Melanoblast, Tyrosinase, Vitiligo |
| priorityDate | 2009-07-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 171.